Investment adviser · CRD 160359
NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
Investment adviser filing (IA)
· Form ADV filed Mar 31, 2026
- Regulatory AUM
- $1.48B Form ADV · Item 5.F
- Client accounts
- 14 Accounts, not individual clients
- Employees
- 18 Reported in this filing
- Advisory professionals
- 18 Investment advisory functions
Who they report serving
Form ADV · Item 5.DClient types and their share of reported regulatory assets.
| Client type | Clients | Regulatory assets | Share of AUM |
|---|---|---|---|
| Pooled investment vehicles | 14 | $1,483,025,000 | 100.0% |
Filing source
Form ADV 2038092 · Mar 31, 2026 · Item 5.D
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Private funds & service providers
50+ Private fundsThe count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.
Browse the first 49 funds across 7 pages.
NOVAQUEST PHARMA OPPORTUNITIES FUND V, L.P.Private Equity Fund · Last reported Mar 31, 2026$603MGross asset value
Form D fundraising filings
NovaQuest Pharma Opportunities Fund V, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO CAYMAN LTD.
PCAOB 2162
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-8940485931
- Reported beneficial owners
- 19
- Minimum commitment
- $25M
- Form D file number
- 021-289380
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST PHARMA OPPORTUNITIES FUND V (DELAWARE), L.P.Private Equity Fund · Last reported Mar 31, 2026$377MGross asset value
Form D fundraising filings
NovaQuest Pharma Opportunities Fund V (Delaware), L.P.
Feeder funds
- NOVAQUEST PHARMA OPPORTUNITIES FUND V (DELAWARE) FEEDER, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO USA, P.C.
PCAOB 243
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-9502844334
- Reported beneficial owners
- 7
- Minimum commitment
- $25M
- Form D file number
- 021-289381
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND (DELAWARE), L.P.Private Equity Fund · Last reported Mar 31, 2026$141MGross asset value
Form D fundraising filings
NovaQuest Animal Health Opportunities Fund (Delaware), L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO USA, P.C.
PCAOB 243
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-8285129310
- Reported beneficial owners
- 2
- Minimum commitment
- $5M
- Form D file number
- 021-421815
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST PHARMA OPPORTUNITIES FUND IV, L.P.Private Equity Fund · Last reported Mar 31, 2026$126MGross asset value
Form D fundraising filings
NovaQuest Pharma Opportunities Fund IV, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO CAYMAN LTD.
PCAOB 2162
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-7328857121
- Reported beneficial owners
- 37
- Minimum commitment
- $25M
- Form D file number
- 021-241580
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST PHARMA OPPORTUNITIES FUND VI, L.P.Private Equity Fund · Last reported Mar 31, 2026$73.9MGross asset value
Form D fundraising filings
NovaQuest Pharma Opportunities Fund VI, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO CAYMAN LTD.
PCAOB 2162
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-4325860423
- Reported beneficial owners
- 3
- Minimum commitment
- $10M
- Form D file number
- 021-479248
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST PHARMA OPPORTUNITIES FUND IV AGGREGATOR, L.P.Private Equity Fund · Last reported Mar 31, 2026$72.9MGross asset value
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO CAYMAN LTD.
PCAOB 2162
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-7528290413
- Reported beneficial owners
- 3
- Minimum commitment
- $25M
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
NOVAQUEST PHARMA OPPORTUNITIES FUND IV (CO-INVEST), L.P.Private Equity Fund · Last reported Mar 31, 2026$53.2MGross asset value
Form D fundraising filings
NovaQuest Pharma Opportunities Fund IV (Co-Invest), L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BDO CAYMAN LTD.
PCAOB 2162
SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35
WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09
Fund details & source
- Fund ID
- 805-3068515556
- Reported beneficial owners
- 2
- Minimum commitment
- $25M
- Form D file number
- 021-253893
Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Services & filing details
Most recent filing: Mar 31, 2026. View historical filings
Reported services
Pooled investment vehicle management
Compensation
Percentage of assets · Performance-based
Principal office
CRD 160359
Filing source
Form ADV 2038092 · Mar 31, 2026 · Items 1 & 5
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.